The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumab. Lee RH, Truong A, Wu X, Kang H, et al. Head Neck 2024;46:129-137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee RH, Truong A, Wu X, Kang H, et al. The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumab. Head Neck 2024;46:129-137.
PMID: 37897202